Olympus Wins CMS Reimbursement Rates for New GI Surgery Codes
CMS has finalized 2027 reimbursement valuations for new endoscopic submucosal dissection CPT codes, expanding U.S. patient access to organ-sparing GI procedures.
Olympus Corporation announced Wednesday that the Centers for Medicare & Medicaid Services has published final valuations and calendar year 2027 reimbursement rates for newly established CPT codes covering endoscopic submucosal dissection, a minimally invasive gastrointestinal procedure designed to remove tumors while preserving the affected organ.
The Tokyo-based medical technology company, which maintains U.S. operations in Center Valley, Pennsylvania, said the finalized CMS rates mark a significant step toward broader domestic adoption of the technique. Endoscopic submucosal dissection, known in the field as ESD, allows physicians to excise early-stage GI lesions without resorting to surgical organ removal, potentially reducing patient recovery time and procedural risk.
Read more Kennedy Funding Closes $1.1M Loan for Maryland Church and Daycare →
Securing dedicated CPT codes with defined reimbursement values is widely regarded in the medical device industry as a prerequisite for mainstream clinical uptake in the United States. Without established billing pathways, hospitals and outpatient centers face financial uncertainty that can deter investment in new equipment and physician training, limiting patient access regardless of a procedure's clinical merits.
Olympus framed the CMS action as directly advancing access to organ-sparing care for American patients who might otherwise face more invasive surgical options. The company did not disclose the specific dollar amounts assigned to the new codes in its announcement.
Continue reading at Banking & Financial Services